Evaluation of the effect of multipoint intra-mucosal vaginal injection of a specific cross-linked hyaluronic acid for vulvovaginal atrophy: a prospective bi-centric pilot study. [PDF]
Berreni N +4 more
europepmc +1 more source
Understanding the Benefits of CO2 Laser Treatment for Vulvovaginal Atrophy. [PDF]
Jankovic S +5 more
europepmc +1 more source
Assessing the Noninferiority of the Spermidine Hyaluronate Complex Relative to 17β-Estradiol Treatment in the Ovariectomized Murine Model of Vulvovaginal Atrophy. [PDF]
Ghisalberti CA, Tezze C.
europepmc +1 more source
Prevalence of urinary tract infections in women with vulvovaginal atrophy and the impact of vaginal prasterone on the rate of urinary tract infections. [PDF]
Rubin R +5 more
europepmc +1 more source
Effect of Vitamin D Supplement on Vulvovaginal Atrophy of the Menopause. [PDF]
Kamronrithisorn T +4 more
europepmc +1 more source
Experience with ospemifene in a patient with vulvovaginal atrophy and dyslipidemia: a case study. [PDF]
Rodríguez SPG.
europepmc +1 more source
Multifaceted Impact of CO2 Laser Therapy on Genitourinary Syndrome of Menopause, Vulvovaginal Atrophy and Sexual Function. [PDF]
Jankovic S +5 more
europepmc +1 more source
Effect of Vaginal Laser and Topical Therapies on Vulvovaginal Atrophy Symptoms in Breast Cancer Patients: A Systematic Review and Meta-Analysis. [PDF]
Lőczi LL +11 more
europepmc +1 more source
Experience with ospemifene in patients with vulvovaginal atrophy treated with laser therapy: case studies. [PDF]
Salcedo FL, Blanco ZE.
europepmc +1 more source
Effects of vaginal estrogen on serum estradiol during aromatase inhibitor therapy in breast cancer patients with vulvovaginal atrophy: a prospective trial. [PDF]
Faltinová M +8 more
europepmc +1 more source

